Clinical Trial Update: A Trial of MHB088C in Advanced Extrapulmonary Neuroendocrine Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating MHB088C for advanced extrapulmonary neuroendocrine cancer, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extrapulmonary Neuroendocrine Tumor

Drugs mentioned

• MHB088C

Snippet

Sponsor: Beijing GoBroad Hospital | Conditions: Advanced Extrapulmonary Neuroendocrine Cancer | Phase 2 | Status: NOT_YET_RECRUITING